Horizon Technology Finance

Horizon Technology Finance Management, LLC is a venture lending firm that specializes in providing structured debt products, including senior and subordinated venture loans, secured working capital loans, and equipment loans, to development-stage companies primarily in the technology and life sciences sectors. Founded in 2003 and headquartered in Farmington, Connecticut, with additional offices in Pleasanton, California, and Reston, Virginia, Horizon focuses on investments in areas such as cloud computing, biotechnology, and alternative energy. The firm targets companies in the Mid-Atlantic and Western regions of the United States, offering loans ranging from $1 million to $25 million, with repayment terms of up to 48 months. With a team that has collectively originated over $5 billion in venture loans, Horizon aims to support innovative companies by providing essential capital to fuel their growth.

John C. Bombara

Executive Vice President, General Counsel

Gregory E Clark

MD of Technology - East Coast

Daniel S. Devorsetz

Executive Vice President, COO and CIO

Mishone B. Donelson

Senior Vice President

Lucia Lamb

Director of Administration

Kevin J. May

Senior Managing Director

Todd A. McDonald

Managing Director

Gerald A. Michaud

President

Robert R. Michaud

Investment Associate - Technology

Gary P. Moro

Vice President - Senior Credit Officer

Robert D. Pomeroy Jr.

CEO

Daniel R. Trolio

Executive Vice President and CFO

Kevin T. Walsh

Managing Director

78 past transactions

INBRACE

Debt Financing in 2022
Swift Health Systems Inc., a medical device company, develops invisible orthodontic solutions. The company develops InBrace, an orthodontic system that is hidden behind the teeth to correct malocclusion (crooked teeth). Swift Health Systems Inc. was incorporated in 2014 and is based in Irvine, California.

Divergent

Debt Financing in 2022
Divergent Technologies, Inc., based in Los Angeles, California, is focused on transforming the automotive industry through innovative 3D printing technology. Founded in 2014, the company has developed a patented production system that utilizes 3D printed metal connectors, known as Nodes, along with lightweight materials to construct strong and efficient complex structures. This approach eliminates traditional tooling, fostering significant advancements in cost reduction and sustainability within vehicle manufacturing. Divergent's engineering prototype, the Blade, is recognized as the world's first 3D printed supercar, showcasing the potential for radical innovation in automotive design and production. The company has established a strategic partnership with PSA Group to further its mission of empowering a new generation of creative innovators in the automotive sector.

Soli Organic

Debt Financing in 2022
Soli Organic is a company that specializes in the cultivation, packing, and shipping of fresh organic culinary herbs. Founded in 1989 and headquartered in Harrisonburg, Virginia, it operates a production facility in Jefferson, Georgia. Soli Organic offers a diverse range of products, including various herbs such as basil, cilantro, dill, mint, and thyme, as well as herb blends and microgreens. The company provides a year-round supply of these organic herbs to grocery stores, enabling consumers to enjoy locally sourced, flavorful ingredients throughout the year. In addition to its agricultural operations, Soli Organic also offers refrigerated transportation services to ensure efficient delivery. It primarily serves retailers across several states in the southeastern United States, including Georgia, Florida, and North Carolina.

Secure Transfusion Services

Debt Financing in 2022
Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of transfusable blood components. The company is dedicated to helping the blood industry modernize and stabilize by enhancing the vital role that nonprofit blood banks play in ensuring the nation's blood supply.

Aerobiotix

Debt Financing in 2022
Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings.

Interior Define

Debt Financing in 2022
Interior Define Inc. designs, manufactures, and markets furniture products. It offers sofas, occasional chairs, and chaise and L-sectionals. It also provides custom furniture products. The company offers products through its showroom, as well as online. Interior Define Inc. was founded in 2013 and is based in Chicago, Illinois.

IMV Inc

Post in 2021
IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s DepoVax™ platform is a patented formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. IMV Inc has advanced two DepoVax-based cancer vaccines into Phase I human clinical trials. The Company is also advancing a broad infectious disease pipeline including vaccines in such indications as malaria, respiratory syncytial virus (RSV) and anthrax. In addition to the Company’s human health vaccine strategy, it continues to capture value from animal health vaccine applications. IMV Inc has key partnerships in the animal health sector including an agreement with Pfizer Animal Health.

Everstream Analytics

Debt Financing in 2021
Everstream Analytics is a supply chain risk analytics company that focuses on enhancing the resilience and agility of clients' supply chains. The company offers a platform that tracks supply chain risks and integrates with clients' procurement, logistics, and business continuity systems to provide comprehensive visibility of potential disruptions. By leveraging data science, proprietary intelligence, and a team of multilingual specialists, Everstream monitors global risks and events in real-time, allowing clients to respond swiftly to emerging challenges. The platform also combines risk assessments with business performance indicators, helping organizations develop risk profiles and identify critical hotspots. Through the use of heat maps and actionable insights, Everstream enables companies to manage risks effectively, ensuring business continuity and transforming potential disruptions into competitive advantages.
Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to developing therapies for diseases associated with mitochondrial dysfunction, which includes both rare genetic disorders and common age-related conditions. The company's lead product candidate, Elamipretide, aims to address these health issues, while additional candidates like SBT-20 and SBT-272 are being explored for their potential benefits in stabilizing mitochondrial function and treating neurodegenerative diseases, respectively. Founded in 2006 and based in George Town, Cayman Islands, Stealth BioTherapeutics collaborates with patients and advocacy groups to deepen its understanding of the challenges faced by those with mitochondrial diseases and to raise awareness of their therapeutic programs.

Nogin

Debt Financing in 2021
Nogin is an Intelligent Commerce Platform that enables leading brands to keep pace with big retail, drive predictable profitability, exponential growth, and grow rapidly into the future of commerce.

Embody

Venture Round in 2021
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, established in 2014. The company specializes in the development and commercialization of implantable medical devices aimed at soft tissue restoration and regeneration. Embody focuses on creating innovative biomaterials for challenging orthopedic procedures, particularly in tendon and ligament repair, catering to the needs of warfighters, athletes, and the general public. Their product offerings include collagen-based microfiber implants designed for critical applications such as Achilles and rotator cuff repairs. Utilizing advanced technologies like microfluidic biofabrication and electrospinning, Embody aims to replicate the biological and biomechanical properties of native tissue, thereby enhancing the healing process and restoring pre-injury performance for patients suffering from sports-related injuries.

Embody

Debt Financing in 2021
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, established in 2014. The company specializes in the development and commercialization of implantable medical devices aimed at soft tissue restoration and regeneration. Embody focuses on creating innovative biomaterials for challenging orthopedic procedures, particularly in tendon and ligament repair, catering to the needs of warfighters, athletes, and the general public. Their product offerings include collagen-based microfiber implants designed for critical applications such as Achilles and rotator cuff repairs. Utilizing advanced technologies like microfluidic biofabrication and electrospinning, Embody aims to replicate the biological and biomechanical properties of native tissue, thereby enhancing the healing process and restoring pre-injury performance for patients suffering from sports-related injuries.

Cerecor

Post in 2021
Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases, with a particular focus on inherited metabolic disorders. The company's pipeline includes therapies such as CERC-801, CERC-802, and CERC-803, which have completed phase I clinical trials. Additionally, Cerecor is developing CERC-007, an anti-IL-18 monoclonal antibody for autoimmune inflammatory diseases, and CERC-006, a dual mTOR inhibitor for complex lymphatic malformations. Other notable developments include CERC-002 for pediatric-onset Crohn's disease, CERC-913 for mitochondrial disorders, and CERC-005 for rare auto-inflammatory diseases. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions. Founded in 2011 and headquartered in Rockville, Maryland, the company was previously known as Ceregen Corporation before rebranding in March 2011.

LiquiGlide

Debt Financing in 2021
LiquiGlide Inc. develops custom-designed liquid-impregnated coatings in the United States. It offers its products for various slippery surfaces, such as teflon, superhydrophic, and oil surfaces. It serves manufacturing, oil and gas, processing, aviation, utilities, power plants, water, chemical, and medical industries; and food and beverage, health and beauty, and household product industries. The company was founded in 2012 and is based in Cambridge, Massachusetts.

Cerecor

Post in 2021
Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases, with a particular focus on inherited metabolic disorders. The company's pipeline includes therapies such as CERC-801, CERC-802, and CERC-803, which have completed phase I clinical trials. Additionally, Cerecor is developing CERC-007, an anti-IL-18 monoclonal antibody for autoimmune inflammatory diseases, and CERC-006, a dual mTOR inhibitor for complex lymphatic malformations. Other notable developments include CERC-002 for pediatric-onset Crohn's disease, CERC-913 for mitochondrial disorders, and CERC-005 for rare auto-inflammatory diseases. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions. Founded in 2011 and headquartered in Rockville, Maryland, the company was previously known as Ceregen Corporation before rebranding in March 2011.

Fingerlix

Series C in 2021
Launched in 2016, Fingerlix is the brainchild of 4 foodies. Their purpose is to spread Joy through food by easing up cooking and exploration. They believe that Joy stems from spending more time with family and less time in the kitchen. Joy is maximum when they discover something new and different that entices their taste buds. Joy also comes from making healthier, happier food choices that leave us with a feeling of goodness. Through their Ready-to-Cook & Ready-to-Eat food options, they want to be a part of your cooking journey, partnering you, everyday - day after day. And they do their best to make that happen – sourcing choicest ingredients, maintaining extremely high hygiene standards and above all, inspiring your magical touch to transform every dish into ‘Your dish’.

Canary Medical

Debt Financing in 2021
Canary Medical Inc. specializes in the development of medical implant and data management devices that facilitate remote patient monitoring and data collection. The company's primary innovation is the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device designed to gather and process medical data without requiring direct physician intervention. Additionally, Canary Medical creates smart medical devices that provide self-reports on patient activity, recovery, and treatment outcomes, thereby enhancing patient compliance. Established in 2013 and headquartered in Vancouver, Canada, the company has also formed a joint venture with BioScience Managers to launch CHARM Informatics, a platform aimed at collecting and monetizing data from implantable and wearable medical devices.

Alula Holdings

Debt Financing in 2021
Alula Holdings is a smart security company offering a completely integrated smart security platform. The platform delivers security simplified for independent security dealers and installers and the customers who rely on their service and expertise. The company dedicated to making smart security simple for dealers. It was founded in 2018 and is based in Hudson, Wisconsin.

IDbyDNA

Debt Financing in 2020
IDbyDNA, Inc. specializes in metagenomics technologies aimed at identifying infectious diseases. The company has developed the Explify platform, which assists laboratories in the detection of various pathogens. In addition to its technology solutions, IDbyDNA offers testing services, including respiratory and research services, catering to a diverse clientele that includes hospitals, reference labs, clinical research institutions, and the biopharma sector. Founded in 2014 and headquartered in Salt Lake City, Utah, IDbyDNA aims to empower clinicians and researchers to identify pathogens from any sample, enhancing the capabilities of infectious disease diagnostics.

Corinth MedTech

Debt Financing in 2020
Corinth MedTech, Inc. is a medical technology company based in Cupertino, California, that specializes in manufacturing disposable bipolar transurethral and transcervical resectoscopes. Founded in 2011, the company has developed a bipolar transurethral resection system designed for endoscopically controlled tissue removal. This system is specifically intended for male patients suffering from benign prostatic hyperplasia (BPH) and for female patients with conditions such as abnormal uterine bleeding, fibroids, or polyps that necessitate hysteroscopic tissue removal. Corinth MedTech aims to provide effective solutions for these medical conditions through its innovative product offerings.

Sonex Health

Debt Financing in 2020
Sonex Health, LLC develops micro-invasive surgical device. The company offers SX-One MicroKnife with Meerkat Technology to treat carpal tunnel syndrome in orthopedic patients through an ultrasound-guided carpal tunnel release (USCTR) procedure. It also offers Stealth MicroGuards and TCL Blade devices. The company was founded in 2014 and is based in Rochester, Minnesota.

Getaround

Debt Financing in 2020
Getaround, Inc. operates an online marketplace for peer-to-peer car sharing and local car rentals, allowing users to rent vehicles from people nearby. Founded in 2009 and headquartered in San Francisco, the platform offers a diverse range of vehicles, including convertibles, luxury cars, SUVs, and trucks, available for rent by the hour or day. Getaround's innovative technology, known as Getaround Connect, facilitates a seamless car-sharing experience by enabling users to unlock and access vehicles without needing to meet the car owner or handle physical keys. The service is designed to eliminate the traditional hassles associated with car rentals, such as waiting in line and completing paperwork. Getaround provides users with a $1 million insurance policy and 24/7 roadside assistance, making it a safe option for renters. The company operates in major metropolitan areas across the United States, helping individuals offset car ownership costs while promoting more sustainable transportation options.

Topia

Debt Financing in 2020
Topia specializes in Global Talent Mobility, providing a comprehensive platform that allows companies to manage and engage their employees across the globe. Their solution supports various forms of employee movement, including remote work, business travel, and traditional relocations. By automating the entire talent mobility process, Topia enhances employee experiences and helps organizations align mobility strategies with their broader talent and business objectives. The platform addresses critical aspects such as scenario-based planning, compliance risk management, expat payroll, and reporting, facilitating a seamless experience for both employers and employees. Topia serves a diverse range of reputable brands, empowering them to ensure that the right personnel are located where they are needed most, thereby contributing to a competitive advantage in the marketplace.

Magnolia Medical Technologies

Debt Financing in 2020
Magnolia Medical Technologies, Inc. is a Seattle-based company that specializes in the development and manufacturing of medical devices aimed at enhancing the accuracy of diagnostic blood culture tests. Its flagship product, SteriPath, is a vacuum-assisted blood collection system designed to divert contaminants from the initial blood sample, thereby reducing the incidence of blood culture sample contamination. The company markets its products through distributors across the United States and has built a robust intellectual property portfolio, consisting of over 70 issued patents and more than 50 pending applications. Founded in 2011, Magnolia Medical Technologies is committed to improving diagnostic specimen quality and increasing the accuracy of critical laboratory tests.

Ceribell

Debt Financing in 2020
CeriBell, Inc. designs and manufactures medical devices for acquisition and interpreting electroencephalography (EEG) data in patients with various neurological conditions. It offers Ceribell EEG system that includes Ceribell EEG Headband that allows healthcare providers to accommodate various hair types and head sizes; and Ceribell EEG Recorder, a pocket-sized, battery operated recorder that provides clinical quality EEG and on-device EEG display. It serves medical staff in hospital ICUs, inpatient units, and emergency departments. CeriBell, Inc. was formerly known as Brain Stethoscope, Inc. The company was incorporated in 2014 and is based in Mountain View, California.

Castle Creek Biosciences

Debt Financing in 2020
Castle Creek Biosciences, Inc. is a gene therapy company based in Exton, Pennsylvania, dedicated to developing and commercializing innovative, personalized gene therapies for rare and serious diseases, particularly those affecting the skin and connective tissue. Founded in 2015, the company aims to address significant unmet medical needs through its specialized pipeline of therapies targeted at these conditions.

OutboundEngine

Debt Financing in 2019
OutboundEngine is an Austin, TX-based marketing technology company that helps businesses grow by making online marketing simple. The company’s SaaS platform automates email marketing, social media posting, online review collection and more for over 10,000 customers. Founded in 2012, OutboundEngine is ranked No. 95 on the Inc. 5000 and has been consistently named a top workplace in Austin. For more information, please visit www.outboundengine.com

Meditrina

Debt Financing in 2019
Meditrina, Inc., founded in 2016 and based in San Jose, California, specializes in developing innovative medical devices for tissue removal solutions related to intrauterine pathology. The company provides the Aveta system, designed for healthcare professionals to facilitate hysteroscopic diagnostic and therapeutic procedures, including the removal of polyps and fibroids. In addition to its tissue removal products, Meditrina is also focused on creating fully disposable endoscopes and a comprehensive visualization system intended for use in both office and clinical settings, catering to various medical procedures.

Encore Dermatology

Debt Financing in 2019
Encore Dermatology is a privately held fully-integrated dermatology company that provides prescription therapies and medical devices to dermatologists. It provides a range of medical dermatology products, treating a number of topical disease states that enable patients to get improved skin care and treatment with ease. Encore Dermatology was established in 2015 and is headquartered in Malvern, Pennsylvania.

Mustang Bio

Post in 2019
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.

CSA Medical

Venture Round in 2019
CSA Medical, Inc. develops and manufactures innovative spray cryotherapy medical devices aimed at the destruction of unwanted tissue in various medical fields, including dermatology, gynecology, and general surgery. The company's flagship product, the truFreeze spray cryotherapy device, utilizes cold liquid nitrogen as a cryosurgical tool, allowing for the targeted destruction of tissue while promoting the regeneration of healthy tissue. Additionally, CSA Medical offers the Rapid AV Spray Kit, which enhances the truFreeze system by reducing the time required for liquid nitrogen application. Founded in 1993 and originally known as Crymed Technologies, the company rebranded to CSA Medical in 2006 and is headquartered in Baltimore, Maryland, with a research and development facility located in Lexington, Massachusetts.

MacuLogix

Debt Financing in 2018
MacuLogix, Inc. specializes in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company offers the AdaptDx, a fully automated dark adaptometer designed to aid eye care professionals in detecting and tracking AMD at its earliest stages, potentially up to three years before it becomes visible. This early detection capability allows for timely intervention, which can help prevent vision loss. MacuLogix markets its products through distributors in the United States and internationally, as well as online, to ensure accessibility for healthcare providers. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix is committed to leveraging the science of dark adaptation to combat preventable blindness associated with AMD.

New Signature

Debt Financing in 2018
New Signature is a cloud-first, full-service Microsoft technology partner that assists businesses of all sizes in addressing their challenges through Microsoft solutions. The company employs a process-driven approach to deliver successful outcomes for complex projects that require creativity, strategic vision, and technical expertise. By conducting rigorous economic analyses, New Signature helps clients make informed investment decisions regarding Microsoft services. The firm provides comprehensive IT support, including planning, design, deployment, customization, and management of Microsoft solutions. Additionally, New Signature focuses on maximizing return on investment by offering tailored user adoption and learning solutions for both business users and IT professionals, thereby promoting trust and credibility through ethical practices.

Ontrak

Post in 2018
Ontrak provides specialized health management services to health plans, employers and unions through a network of licensed and company managed health care providers. Catasys’ integrated substance dependence program, OnTrak is designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching and online tools to aid members in their recovery.

Audacy

Debt Financing in 2018
Since 2003, we help companies driving digital innovation, with disruptive methodologies. We design new brands, new services and new products, in collaboration with our clients and their partners. We assist large groups, start-ups and SMEs in the conduct of disruption (Disrupt), of digital experience design (Design), and the conduct of growth (Scale). Our approach is different from a digital agency: we are structured as a consultancy, with concrete execution abilities in design and in marketing.

Audacy

Debt Financing in 2018
Audacy is a space communications service provider enabling continuous satellite and launch vehicle connectivity from the launchpad to the Moon. Its mission is to deliver anytime, highly operable connectivity that advances humankind to an unparalleled age of space exploration and discovery. The company was founded in 2015 and headquartered in Mountain View, California.

Conventus Orthopaedics

Debt Financing in 2018
Conventus Orthopaedics provides a range of orthopedic and sports medicine services. The physicians specialize in orthopedic surgery, reconstructive surgery, spine surgery, joint replacement, sports medicine, physical therapy, and operative care of fractures, arthritis, strains, sprains, and sports-related injuries. Conventus was formed by a team of medical professionals with the sole purpose of creating less invasive ways to treat challenging periarticular fractures. By leveraging advanced nitinol technology, the Conventus team has developed a platform technology that provides robust fixation and creates reliable repairs. The company was incorporated in 2009 and is based in Maple Grove, Minnesota.

IntelePeer

Debt Financing in 2018
IntelePeer specializes in enhancing business communications through a cloud-based platform that integrates various services, including cloud contact centers and enterprise voice solutions. The company focuses on enabling organizations to improve their communication processes, which in turn drives revenue growth and enhances customer experience. By utilizing omni-channel automation, self-service capabilities, artificial intelligence, and analytics, IntelePeer provides a comprehensive solution that seamlessly integrates with existing business systems. This approach allows companies to make informed decisions while streamlining their communication operations.

Aerin Medical

Debt Financing in 2017
Aerin Medical Inc. is a health technology company based in Sunnyvale, California, focused on developing non-invasive treatment solutions for nasal breathing disorders. Founded in 2011, the company specializes in therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of conditions such as nasal obstruction and chronic rhinitis. Aerin Medical offers procedures and devices, including the VivAer procedure and the RhinAer procedure, along with their corresponding styluses, which allow ENT physicians to treat nasal airway conditions in an office setting under local anesthesia. These innovative solutions aim to improve patient outcomes by providing safe, quick, and effective relief from chronic nasal symptoms while minimizing downtime.
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing proprietary therapeutics for chronic diseases through its innovative ProNeura long-term drug delivery platform. The company's key product, Probuphine, is the first slow-release implant formulation of buprenorphine, designed to provide stable medication levels for up to six months, thereby enhancing patient compliance in the treatment of opioid dependence. Titan also develops ProNeura-Ropinirole, an implant for delivering ropinirole to treat Parkinson's disease, and a similar implant for managing hypothyroidism. The ProNeura technology holds promise for addressing various chronic conditions by ensuring consistent drug delivery, which can improve patient outcomes. In December 2012, Titan entered a licensing agreement granting Braeburn Pharmaceuticals exclusive commercialization rights to Probuphine in the U.S. and Canada, receiving significant financial incentives tied to regulatory approvals and sales milestones. Additionally, Titan receives royalties from the sales of Fanapt, an atypical antipsychotic, further supporting its development efforts.

PebblePost

Debt Financing in 2017
PebblePost is the leading digital-to-direct mail marketing platform. They capture online interest and intent data to send relevant direct mail that activates buying decisions at home and drives conversions everywhere. The company invented Programmatic Direct Mail to help brands convert more shoppers into buyers using advanced targeting, algorithmic optimization, attribution, and quantitative analysis. PebblePost is a venture-backed company based in New York.

IgnitionOne

Debt Financing in 2017
IgnitionOne, Inc. develops cloud-based digital marketing software solutions designed for online marketers globally. The company offers a comprehensive Marketing Hub Data Management Platform that consolidates customer information across various channels and touchpoints, alongside a Digital Marketing Dashboard that provides insights into audience activities and campaign performance. Its Digital Marketing Suite includes analytics tools and management solutions for creative assets and search optimization. Additionally, IgnitionOne specializes in website personalization and email optimization. Founded in 2004 and headquartered in New York, IgnitionOne aims to empower enterprise marketers by providing a unified platform that leverages customer data for effective omnichannel targeting and personalization. The company was previously known as SearchIgnite, Inc. until its rebranding in 2011 and is a former subsidiary of 360i LLC.

Receptiv

Venture Round in 2016
Receptiv is a mobile video advertising platform that connects brands with receptive users during significant moments to enhance advertising performance. Established in 2011 as MediaBrix and rebranded in 2017, Receptiv uses emotional targeting and audience intelligence to optimize ad delivery. Its first-party data management platform, Motiv, leverages insights from 150 million device IDs to create contextualized brand engagements. Receptiv operates through both programmatic and managed services, facilitating interactions across over 1,300 premium apps and generating 500 million key moments monthly. The company, based in New York, serves a diverse range of prominent brands, including Mars, Coca-Cola, and Microsoft, and is backed by investors such as Edison Partners and Revel Partners. As of 2018, Receptiv operates as a subsidiary of Verve Wireless, Inc.

ScoreBig

Debt Financing in 2016
ScoreBig, Inc. operates a website that allows fans to save on tickets for live events, including sports, music, and theater. Founded in 2009 and based in Hollywood, California, the company offers consumers discounts of up to 60% on tickets for various events, from professional and college sports to concerts and family shows. ScoreBig.com is recognized as the first opaque sales channel in the $20 billion live event industry, helping teams and organizations sell unsold tickets without the risks associated with traditional discounting methods. As of November 2016, ScoreBig, Inc. functions as a subsidiary of Ticket Software, LLC. The company's leadership includes individuals with experience in the NBA, NFL, theater, and e-commerce, highlighting its strong connections within the live entertainment industry.

Avalanche Technology

Debt Financing in 2016
Avalanche Technology, Inc. develops and markets a non-volatile spin transfer torque magnetic random access memory device. It offers its device for applications in mobile (consumer wearable devices), Internet of Things, enterprise storage, computing, networking, telecommunication, automotive, and other industries. Avalanche Technology, Inc. was formerly known as Yadav Technology Inc. The company was incorporated in 2006 and is based in Fremont, California.

Nomi

Debt Financing in 2016
Nomi's Marketing Platform helps businesses optimize their brick and mortar stores just like their website.

Digital Signal

Debt Financing in 2016
Digital Signal specializes in three-dimensional long-range facial recognition solutions for government and commercial clients. It offers enterprise biometric solutions and customized applications to suit customer needs. The company was founded in 2001 and is headquartered in Chantilly, Virginia.

New Haven Pharmaceuticals

Debt Financing in 2015
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.

Bridge2 Solutions

Debt Financing in 2015
Bridge2 Solutions is the leading innovator in the world of incentive, consumer and performance rewards. Bridging Performance Improvement agencies with best-in-class retail and service organizations to create a new business model for reward fulfillment that re-defines the industry.

Medsphere Systems

Debt Financing in 2015
Medsphere Systems Corporation specializes in healthcare information technology solutions, primarily through its open-source electronic health record platform, OpenVista. This platform encompasses a wide range of functionalities, including clinical, financial, and patient accounting systems, as well as modules for laboratory, pharmacy, radiology, nutrition, and multi-disciplinary treatment planning. In addition to its software offerings, Medsphere provides a variety of services such as implementation, training, system and software engineering, project management, and IT infrastructure support. The company caters to a diverse clientele, including critical access hospitals, acute care facilities, behavioral health centers, and physician practices. Founded in 2002 and headquartered in Carlsbad, California, Medsphere aims to enhance patient care and streamline clinical workflows through its comprehensive healthcare technology solutions.

SilkRoad Technology

Debt Financing in 2015
SilkRoad Technology, Inc. is a global provider of cloud-based talent management solutions, offering a comprehensive suite of services designed to help organizations find, attract, develop, and retain talent. Their offerings include the SilkRoad Suite Start for Talent Acquisition, SilkRoad Recruiting for utilizing social channels in recruitment, and SilkRoad Onboarding for employee onboarding. Additionally, the company provides SilkRoad HRMS for managing employee data and SilkRoad Performance for employee performance management. With a focus on user engagement and collaboration, the SilkRoad Life Suite integrates Talent Acquisition, Talent Development, and HRMS solutions through a user-friendly Talent Portal. SilkRoad Technology serves various industries, including financial services, healthcare, education, manufacturing, professional services, and retail. Founded in 2003 and headquartered in Chicago, Illinois, the company has multiple locations across the United States and internationally, including offices in Canada, Australia, the United Kingdom, France, Denmark, Japan, and the Philippines.

SavingStar

Debt Financing in 2015
SavingStar, Inc. is a cash back platform that provides rewards for grocery and online shopping. Launched in 2010 and based in Waltham, Massachusetts, the platform allows users to earn cash back by linking offers to their supermarket and drugstore loyalty cards or by submitting receipts. Users can earn double cash back when shopping at various online retailers. The service is designed to streamline the shopping experience by eliminating the need for paper coupons, as offers are automatically validated and credited to users' accounts. Additionally, SavingStar enables brands to promote specific products through incentives and rewards that encourage customer engagement. The company was previously known as SaveWave Inc. before rebranding in 2011 and operates as a subsidiary of Quotient Technology Inc.

ScoreBig

Debt Financing in 2015
ScoreBig, Inc. operates a website that allows fans to save on tickets for live events, including sports, music, and theater. Founded in 2009 and based in Hollywood, California, the company offers consumers discounts of up to 60% on tickets for various events, from professional and college sports to concerts and family shows. ScoreBig.com is recognized as the first opaque sales channel in the $20 billion live event industry, helping teams and organizations sell unsold tickets without the risks associated with traditional discounting methods. As of November 2016, ScoreBig, Inc. functions as a subsidiary of Ticket Software, LLC. The company's leadership includes individuals with experience in the NBA, NFL, theater, and e-commerce, highlighting its strong connections within the live entertainment industry.

NinePoint Medical

Debt Financing in 2015
NinePoint Medical, Inc. is a transformational medical device company developing innovative, real-time, in vivo pathology devices. The company's first goal is to develop a device that enables remote pathology, or telepathology, which would facilitate immediate review of images during diagnostic procedures. This capability could potentially provide physicians with immediately actionable information and eventually allow them to pursue therapeutic remedies at the time of diagnosis. This convergence of access, diagnosis and treatment during one procedure is expected to improve patient experiences and outcomes, improve the efficiency of care and provide important savings to the healthcare system. Headquartered in Cambridge, Mass., NinePoint is backed by Third Rock Ventures and Prospect Venture Partners.
Palatin Technologies, Inc. is a biopharmaceutical company focused on developing targeted receptor-specific therapeutics to address various medical conditions with significant unmet needs. The company's lead product, Vyleesi, is a melanocortin receptor agonist designed to treat premenopausal women with acquired, generalized hypoactive sexual desire disorder. In addition, Palatin is advancing several other drug candidates, including oral PL8177, a selective melanocortin receptor 1 agonist aimed at treating inflammatory bowel diseases, and systemic PL8177 for non-infectious uveitis and COVID-19. The company is also developing PL9643 for anti-inflammatory ocular conditions, particularly dry eye disease, and PL3994, a natriuretic peptide receptor-A agonist for cardiovascular issues. Furthermore, PL5028 is being explored as a treatment for cardiovascular and fibrotic diseases. Founded in 1986 and based in Cranbury, New Jersey, Palatin Technologies is committed to creating innovative therapies that address critical health challenges.
Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

ZetrOZ

Debt Financing in 2014
ZetrOZ is revolutionizing the ultrasound industry by introducing proprietary generator technology that is more efficient, more portable, and more economically viable than any ultrasound generator presently available.

InVisage Technologies

Debt Financing in 2014
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Argos Therapeutics

Post in 2014
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.

IntegenX

Debt Financing in 2014
IntegenX Inc. specializes in developing human DNA identification solutions, utilizing advanced fluidics, optics, and biochemistry to create automated systems for DNA-based human identity testing. The company’s flagship product, the RapidHIT System, provides a sample-to-answer solution for STR-based human identification, generating standardized DNA profiles from buccal swabs and other samples. Additionally, IntegenX offers the RapidHIT GlobalFiler Express Kit for processing various swab types and crime scene samples, as well as RapidHIT PowerPlex 16 HS kits. The company distributes its products through various international channels, including markets in Europe and Asia. Founded in 2003 and based in Pleasanton, California, IntegenX was previously known as Microchip Biotechnologies, Inc. and rebranded in 2010. As of 2018, it operates as a subsidiary of Thermo Fisher Scientific Inc.

SpringCM

Debt Financing in 2014
SpringCM Inc. is a cloud-based document and contract management platform that facilitates workflow creation and document collaboration within organizations. Its offerings include a comprehensive contract management system that optimizes the contract lifecycle—from creation and negotiation to approvals, signatures, archiving, and renewals. Additionally, SpringCM provides a digital asset management system to streamline the management, sharing, and collaboration of content, as well as tools for managing sales quotes, proposals, and contracts. The platform allows users to store, organize, search, and share content easily, both internally and externally. SpringCM also offers consulting, training, and support services, with solutions tailored for various sectors, including legal, IT, operations, sales, human resources, public sector, procurement, and finance. Deployed as Software-as-a-Service and accessible via a mobile application, SpringCM emphasizes security and ease of use. Founded in 2005 and headquartered in Chicago, Illinois, the company operates as a subsidiary of DocuSign, following its acquisition in 2018.

Mblox

Debt Financing in 2014
Founded in 1999, Mblox are the original SMS company. With over 100 direct carrier relationships and a global reputation for expertise in mobile messaging, they are trusted by more companies to carry their mission-critical traffic than any other service. Their cloud based mobile messaging platform processes 7 billion mobile messages a year on behalf of more than 4,000 customers. They provide services to fit any size business, from the small start-up to the largest multinational organisation. Every customer has access to 24/7 email support as standard, provided by an in-house team of experts. In addition they offer a variety of support packages to meet your business needs.

GenePeeks

Debt Financing in 2014
GenePeeks, Inc. is a genetic information company based in New York, established in 2009. The company focuses on reducing the risk of heritable diseases by utilizing patented software that simulates the genetic recombination and reduction that occurs during human reproduction. This technology digitally weaves together the DNA of prospective parents, generating a preview of a future child's genetic profile. By analyzing Next-Gen sequencing data, GenePeeks identifies disease risks that existing pre-conception screening tools cannot detect. The software produces tens of thousands of “virtual genomes,” providing valuable insights that help families protect the health of future generations.

Social Intelligence

Debt Financing in 2014
Social Intelligence Corp. is a company based in Santa Barbara, California, that specializes in providing SaaS-based tools and services focused on social media data and analytics for commercial and government organizations. Founded in 2010, the company offers a diverse range of products, including investigative reports, predictive scoring algorithms, and background screening services. Its solutions cater to various sectors, such as employment, insurance, corporate investigations, and government services, ensuring compliance with relevant laws, including the Fair Credit Reporting Act. Social Intelligence emphasizes the legal and responsible use of publicly available online information, aiming to enhance safety and reduce costs for its clients. With a growing team of over 50 employees, the company prioritizes privacy, productivity, and community involvement in its operations.

AccuVein

Debt Financing in 2014
AccuVein Inc. is a manufacturer of vein visualization solutions aimed at improving vascular access for healthcare professionals. Founded in 2006 and based in Medford, New York, the company specializes in portable, non-contact devices that illuminate peripheral veins, enabling practitioners to see a detailed map of veins beneath the skin. Its flagship product, the AV400, is designed to enhance procedures such as blood draws, IV infusions, and cosmetic injections by allowing accurate vein identification and access. AccuVein's offerings also include various hands-free and wheeled solutions that cater to different medical settings, including surgery centers, imaging centers, and long-term care facilities. The company distributes its products through a network of sales representatives and distributors both in the United States and internationally.

Mederi Therapeutics

Debt Financing in 2013
Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.

Overture Networks

Debt Financing in 2013
Overture Networks develops and manufactures high-speed carrier ethernet edge and aggregation solutions. Its products combine packet-switched and circuit-switched areas into a single architecture-at cost points to offer carrier Ethernet services to any size location over copper, fiber, or optical transport.

Valore

Debt Financing in 2012
Valore operates an online marketplace designed for college students to buy, sell, and rent textbooks and other educational resources. Based in San Diego, ValoreBooks.com connects students with over 14,000 booksellers nationwide, offering textbooks at discounts of up to 90 percent off the list price, significantly lower than traditional campus bookstores. In addition to its extensive selection of affordable textbooks, Valore provides interactive tools and advice on college costs and student loans. The company is recognized for its commitment to customer service and for giving back to students, enhancing the overall educational experience.

Radisphere Radiology

Debt Financing in 2012
Radisphere National Radiology Group, Inc. specializes in providing radiology delivery solutions to hospitals and health systems, operating in over 28 states with more than 100 clients. The company offers cloud-based technology solutions, including RadVision and RadPerform, which enhance transparency in performance, quality data analysis, and benchmarking across systems. These tools help manage performance, eliminate clinical variation, and reduce labor costs through effective capacity planning and resource allocation. Radisphere's services also facilitate real-time decision support and timely communication of critical findings, while providing access to national teleradiology networks for continuous coverage. By centralizing radiology management, Radisphere enables health systems to improve care quality and reduce costs, establishing measurable standards for diagnostic accuracy and patient care. Founded in 2001 and based in Beachwood, Ohio, Radisphere was previously known as Franklin & Seidelmann, LLC before its rebranding in 2010.

Grab Media

Private Equity Round in 2009
Grab Media (formerly Grab Networks) is a leading premium video distribution company that connects premium video content from a wide collection of professional sources and brand-name advertisers to ideal viewers. Marketers rely on Grab Media to position their message in front of large-scale, engaged audiences, so they can focus on brand promotion.

Tagged

Debt Financing in 2008
Tagged.com was launched in 2004, and is an explosively growing social-networking portal developed specifically for teens aged 13 through 19. Emerging as the premier brand in the lucrative teen demographic, Tagged.com is rapidly becoming the number one teen site on the web.

Revance Therapeutics

Debt Financing in 2008
Revance Therapeutics, Inc. is a biotechnology company focused on the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic uses. The company’s lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing clinical trials for various conditions, including glabellar lines, cervical dystonia, adult upper limb spasticity, and chronic migraine. In addition, DAXI is being evaluated for cosmetic applications such as forehead lines and lateral canthal lines. Revance is also developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic purposes, and it is working on a biosimilar to BOTOX in collaboration with Mylan. Founded in 1999 and originally known as Essentia Biosystems, the company is headquartered in Newark, California.

Ambit Biosciences

Series D in 2007
Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.

Copan Systems

Series C in 2006
COPAN Systems, Inc. specializes in providing storage solutions that focus on managing and protecting long-term persistent data. Founded in 2002 and headquartered in Longmont, Colorado, the company offers a range of products including virtual tape libraries for backup and disaster recovery, as well as archive solutions designed to retain digital assets with efficient file-level storage and retrieval. Its offerings encompass data protection, tiered storage, and energy-efficient power and cooling systems. COPAN Systems serves a diverse clientele across various sectors, including education, finance, government, healthcare, technology, media, and service providers.

Intarcia Therapeutics

Debt Financing in 2005
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for chronic conditions, particularly type 2 diabetes. The company is advancing its lead product, ITCA 650, through a phase 3 clinical program involving four separate clinical trials, aimed at providing patients with long-term stable dosing of an incretin mimetic therapy. Intarcia also offers the Medici Drug Delivery System, a subcutaneous platform designed to enhance the administration of drug therapies for various chronic diseases, including obesity and autoimmune disorders. Founded in 1997 as BioMedicines, the company rebranded to Intarcia Therapeutics in 2004. It is headquartered in Boston, Massachusetts, with additional facilities in Hayward, California, and a research and development center in Durham, North Carolina.